menu
    • menu

    Company profile for NLS Pharmaceutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Safeguarding life and longevity by empowering the brain through all stages of life stands at the core of NLS Pharmaceutics' mission. In 2015 a team of researchers, drug developers and commercial leaders shared a vision of developing safe and effective drugs to measurably improve mental and behavioral disorders. Over the years since then, the team has dedicated itself to turning its vision into reality.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NLS PharmaceuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    The Circle 6 | P.O. Box CH - 8058 Zurich
    Telephone
    Telephone
    +41 44 512 21 50
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nlspharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Newcelx Updates Business Strategy Post-Merger With NLS Pharma
    Newcelx Updates Business Strategy Post-Merger With NLS Pharma

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/newcelx-provides-business-and-strategic-roadmap-update-following-closing-of-merger-with-nls-pharmaceutics-ltd-302602565.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    NLS Pharma & Kadimastem Complete Merger
    NLS Pharma & Kadimastem Complete Merger

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nls-pharmaceutics-ltd-and-kadimastem-ltd-announce-completion-of-merger-302600312.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    NLS Pharma Expands CNS Pipeline With Aex-6Xx Series
    NLS Pharma Expands CNS Pipeline With Aex-6Xx Series

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nls-pharmaceutics-expands-cns-pipeline-with-aex-6xx-series-developed-by-aexon-labs-302599696.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    NLS, Kadimastem Finalize Merger Terms and Kadimastem Delisting
    NLS, Kadimastem Finalize Merger Terms and Kadimastem Delisting

    29 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nls-pharmaceutics-and-kadimastem-announce-completion-of-material-conditions-precedent-for-merger-transaction-and-delisting-date-of-kadimastems-shares-302598112.html

    PR NEWSWIRE
    29 Oct 2025
    Share Share
    NLS, Kadimastem Note BIRD Support for ITOL-102 Diabetes Program
    NLS, Kadimastem Note BIRD Support for ITOL-102 Diabetes Program

    29 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nls-pharmaceutics-and-kadimastem-highlight-continued-bird-foundation-support-for-itol-102-diabetes-program-following-merger-302598239.html

    PR NEWSWIRE
    29 Oct 2025
    Share Share
    NLS and Kadimastem Partner with TargetGene for Cell Therapies
    NLS and Kadimastem Partner with TargetGene for Cell Therapies

    27 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nls-pharmaceutics-and-kadimastem-announce-strategic-collaboration-between-kadimastem-and-targetgene-to-advance-next-generation-gene-edited-cell-therapies-302595227.html

    PR NEWSWIRE
    27 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search